J & J ’s Medical Device Sales Feel the Side Effects of Weight-Loss Drugs

Riding high, Johnson & Johnson reported pharmaceutical sales worth $13.89 billion on Tuesday (Oct 17), a year-over-year growth exceeding 5%. The pharmaceuticals driving its growth are Darzalex, a biologic used for multiple myeloma, and Erleada, a prostate cancer treatment, in addition to several…#johnsonjohnson #darzalex #erleada #imbruvica #abiomed #altopharmacy #teamcubancard #medtechdivision #obese #glp1
Source: Reuters: Health - Category: Consumer Health News Source Type: news